Hepatoprotective effect of an immortal human fetal hepatic cell transplantation on CCL(4)-induced acute liver injury in mice.

Abstract

Hepatocyte transplantation has been widely confirmed in the animal model experiments as an effective method for treatment of fulminant hepatic failure. However, the lack of donor organs remains a major problem. One solution is the development of transplantable hepatocytes. Herein we have transplanted intraperitoneally an established immortalized human fetal hepatic cell line (HL-7702) into CCl(4)-treated mice with acute liver injury to determine whether they provided life-saving metabolic support. The results showed lower levels of blood ammonia and higher content of liver albumin (P < .05) after HL-7702 transplantation versus nontransplanted controls at days 3 and 7. Histologic examination showed the transplantation group to be less affected at day 7 with no difference at day 14. In conclusion, an established immortal human fetal hepatic cell line may be a promising cell source providing life-saving metabolic support as a bioartificial liver device for the treatment of acute liver injury.

• Authors: Y B Yan, H Song, B S Zhong, Z Y Wang, S J Ying, F Wang
• Journal: Transplantation proceedings (Transplant Proc) Vol. 42 Issue 7 Pg. 2782-5 (Sep 2010) ISSN: 1873-2623 [Electronic] United States
• PMID: 20832587 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: 2010. Published by Elsevier Inc.

Chemical References

• Serum Albumin
• Carbon Tetrachloride
• Aspartate Aminotransferases
• Alanine Transaminase

Topics

• Alanine Transaminase (blood)
• Animals
• Aspartate Aminotransferases (blood)
• Carbon Tetrachloride (toxicity)
• Carbon Tetrachloride Poisoning (surgery)
• Cell Line
• Fetus
• Hepatocytes (pathology, transplantation)
• Humans
• Liver (drug effects, pathology)
• Liver Failure, Acute (surgery)
• Liver, Artificial (statistics & numerical data)
• Mice
• Serum Albumin (metabolism)